C4 Therapeutics CFO Lauren White to step down; Kendra Adams named successor
C4 Therapeutics, Inc.
Lauren White resigns as CFO, Treasurer, and principal financial/accounting officer effective September 15, 2023; no disagreement cited.
Kendra Adams appointed CFO effective September 18, 2023; previously SVP, Communications and IR at C4T since Nov 2020.
Mark Mossler appointed Chief Accounting Officer and principal accounting officer effective Sept 18, 2023; previously VP, Corporate Controller since June 2023.
Adams receives $450K base salary, 40% bonus target, option for 111,000 shares, and 25,000 RSUs.
Mossler receives $315K base salary, 30% bonus target.
On September 5, 2023, the Company announced the appointment of Kendra Adams as its Chief Financial Officer, Treasurer and principal financial officer, effective as of Monday September 18, 2023.
The Company has also appointed Mark Mossler as its Chief Accounting Officer and principal accounting officer, effective as of Monday September 18, 2023.
On August 30, 2023, Lauren White informed us of her intent to resign from C4 Therapeutics, Inc. (the “ Company ”), effective as of Friday September 15, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Kendra Adams was appointed as Chief Financial Officer at C4 Therapeutics, Inc..
Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On September 5, 2023, the Company announced the appointment of Kendra Adams as its Chief Financial Officer, Treasurer and principal financial officer, effective as of Monday September 18, 2023.
Mark Mossler was appointed as Chief Accounting Officer at C4 Therapeutics, Inc..
Action
appointed
Role
Chief Accounting Officer
Exact text from the filing
The Company has also appointed Mark Mossler as its Chief Accounting Officer and principal accounting officer, effective as of Monday September 18, 2023.
Lauren White resigned as Chief Financial Officer at C4 Therapeutics, Inc..
Action
resigned
Role
Chief Financial Officer
Exact text from the filing
On August 30, 2023, Lauren White informed us of her intent to resign from C4 Therapeutics, Inc. (the “ Company ”), effective as of Friday September 15, 2023.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.